Navigation Links
Dr. S. Mark McKenna - CEO and Founder of ShapeMed - Atlanta, GA - will be featured on Doctorpreneur with Dr. Jeff Gallups, Dr. Stanford Plavin, and Dr. Christopher Reeves
Date:10/24/2013

Atlanta, GA (PRWEB) October 24, 2013

Dr. S. Mark McKenna, CEO and founder of ShapeMed - http://www.ShapeMed.com, will be a featured guest on the new CBS television show entitled Doctorpreneur. Doctorpreneur, as the name suggests, highlights the entrepreneurial spirit in the medical and healthcare communities. Dr. Jeff Gallups, CEO and Medical Director of the ENT Institute, and Cliff Oxford, founder of the Oxford Center for Entrepreneurs, are the creators and producers of the new show.

"I was pleased to be invited on the inaugural episode of the new show.” says Dr. McKenna. "I have an enormous amount of respect for Jeff (Gallups) and Cliff (Oxford) so I was happy to support their endeavor." Doctorpreneur highlights the entrepreneurial side of medicine and healthcare delivery and will be aired on CBS on Sunday October 27th, 2013 at 5:30pm Est.Dr. McKenna was joined by Dr. Stanford Plavin, MD, President of Mobile Anesthesiologist of Georgia, and Dr. Christopher Reeves, MD, CFO of Concorida Anesthesiology, Inc. Mobile Anesthesiology of Georgia provides first class, mobile, anesthesiology services in non-hospital settings. Dr. Reeves, has patented a unique, yet highly effective, tool that helps surgeons organize and account for surgical utensils in the operating suite, thereby lowering the possibility of OR mistakes and decreasing surgical times.

Dr. McKenna was asked to discuss his practice ShapeMed - http://www.shapemed.com. ShapeMed is an Atlanta, GA based wellness and aesthetics based medical practice that is in the process of launching an innovative, nationwide, physician-partner franchise model. ShapeMed Franchise Development Corporation will begin franchise sales during the first quarter of 2014.

Read the full story
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Dr. S. Mark McKenna CEO of ShapeMed (Atlanta, GA) Launches Innovative Fitness App Nationwide
2. Celebrity MD Dr. S. Mark McKenna Launches Sleek New Weight Loss App for Women – http://www.WeightLossApp.com
3. Wilderness Medicine founder offers health tips for summer season
4. Leah Hoskins, F.I.L.M. Project Founder, Headed to Jail?
5. Internet Speaker, Founder, and President of RevenFlo Web Team, Jason Broadwater, Discusses the Most Essential Marketing Tool Available for Effective Internet Marketing
6. Technology Founders Commit to Combating U.S. Obesity
7. Audiology Services of Chattanooga Inc., Best Clinic for Hearing Aids in Chattanooga, Reveals New Video From Founder
8. Co-Founder of Omega3 Innovations Says Today’s Fish Oil Industry is on the Wrong Track, Sets Up Blog to Help Consumers Understand Why
9. YogaFit’s Founder Beth Shaw Named to LIU Post College of Management Advisory Board
10. Marina Aleksintser, Founder of BikiniMommyOnline & JNL Fitness Model Factory West Coast President, Brings the Hottest Method of Training to Los Angeles
11. Jack Kelly, Founder Of Lazarus House, Has Announced The Release Of His Book, RADICAL RECOVERY: Twelve Recovery Myths - The Addiction Survivor's Guide To The Twelve Steps.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... BUFFALO, N.Y. A novel compound that targets an ... host of cocaine addiction behaviors, including relapse behavior, a ... research provides strong evidence that this may be a ... no effective medications exist., The UB research was published ... last week. , In the study, the compound, RO5263397, ...
(Date:4/23/2014)... that can rapidly screen a large cell population ... that population has been seriously lacking," said Virginia ... Royal Society of Chemistry journal Chemical Science ... coworkers have developed a novel technique that detects ... Sci. , 2014, DOI: 10.1039/C4SC00578C, http://pubs.rsc.org/en/content/articlelanding/2014/sc/c4sc00578c#!divAbstract ). ...
(Date:4/23/2014)... as the United States, it may come as a surprise ... adequate food due to lack of money or other financial ... the University of Illinois using data from the National Health ... are dealing with hunger are also facing negative health and ... over age 60 faced the threat of hungerthat translates to ...
(Date:4/23/2014)... Occupational and Leisure Time Physical Activity on Mobility Limitation ... midlife increases the risk of mobility limitation in old ... is found in a study which followed up 5,200 ... conducted at the Gerontology Research Center in Finland and ... labor is often repetitive, wears the body and lasts ...
(Date:4/23/2014)... disease has been a rapidly evolving pursuit with ... crook in the research road, scientists have found ... associated with the disease. The report, which appears ... could have important implications for developing novel treatments. ... explain that for years, research has suggested a ...
Breaking Medicine News(10 mins):Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:More Americans in their golden years are going hungry 2Health News:Midlife occupational and leisure-time physical activity limits mobility in old age 2
... advanced colorectal cancer as intravenous treatment with a similar ... as those on standard chemotherapy, but the pill caused ... 5-fluorouracil (5-FU), the chemotherapy regimen most commonly used to ... to use and produces fewer side effects, and that's ...
... An experimental estrogen lotion appears to reduce the number of ... from a pivotal-stage trial of the drug Estrasorb. If approved ... therapy in lotion form.// ,The drug's developer Novavax ... lotion reduced by 80% the total number of hot flashes ...
... researchers are warning that blood transfusions can cause a ... to more than 50 deaths// nationwide since 1990. About ... patients receive transfusions each year. Testing for the antibodies ... routine screening of the nation's blood supply. ,The ...
... Women who gain 38 pounds or more while pregnant ... by 40%.,Excess pregnancy weight gain// doesn't increase breast cancer ... for post-menopausal women. ,The study found that ... raise their post-menopausal risk of developing breast cancer by ...
... Food and Drug Administration has approved a new treatment ... radiofrequency energy to// shrink small areas of the cornea, ... Unlike laser in situ keratomileusis (LASIK), in which the ... conductive keratoplasty does not require cutting or tissue removal. ...
... Drug Administration recommends pregnant women to avoid swordfish, shark, ... oysters, marlin, halibut, pike, walleye, white croaker, and largemouth ... and young children to eat only small amounts of ... Food and Drug Administration softened its warning to pregnant ...
Cached Medicine News:
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: Global ... Systems -- Focus on End Users ... OBJECTIVES A drug delivery system ...
(Date:1/14/2014)... , Jan. 14, 2014 HeartWare International, Inc ... of less invasive, miniaturized circulatory support technologies that are ... that it expects revenues for the fourth quarter of ... 2013 revenues to approximately $208 million. "Our ...
(Date:1/14/2014)... HARRISBURG, Pa. , Jan. 14, 2014 Dynamic Healthcare ... ("GMH"), announced today that it acquired Progressive Home Medical Equipment, ... January 7, 2014. The terms of the acquisition were not ... medical equipment ("DME") company providing a wide range of sleep, ...
Breaking Medicine Technology:Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... April 13, 2011 Cephalon, Inc. (Nasdaq: ... CXS Holdings Pty Ltd (Cephalon), has lodged the offer ... for ChemGenex Pharmaceuticals Limited (ASX: CXS) (ChemGenex) with the ... offering a 58 percent premium to the one-month volume ...
... Pharmaceuticals, Inc., the leader in the development of neurosteroids ... of a $3 million grant by the U.S. Department ... the treatment of Fragile-X Syndrome (FXS). Ganaxolone modulates GABA-A ... Early research suggests that normalizing neurosteroid levels with ganaxolone ...
Cached Medicine Technology:Cephalon Lodges Bidder's Statement for A$167 Million Offer for ChemGenex Pharmaceuticals 2Cephalon Lodges Bidder's Statement for A$167 Million Offer for ChemGenex Pharmaceuticals 3Marinus Pharmaceuticals Announces U.S. Department of Defense Grant to Study Ganaxolone in Fragile-X Syndrome 2
Tube for Right Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. With Carina hook. X-ray opaque line. Gradua...
Laser resistant tubes for use with CO2 and KTP Lasers., ,Designed for airway management during laser surgery of the larynx or other areas in close proximity to the trachea....
Laryngectomy Tubes with special J-shape for convenient placement through a tracheostomy stoma....
SPIRAL-FLEX® Reinforced Oral/Nasal Cuffed Endotracheal Tubes...
Medicine Products: